Related Experiment Videos
Some pharmacologic characteristics of the human vas deferens
Investigative Urology
|March 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Prostate cancer and prostatic diseases·2012
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
Prostate cancer and prostatic diseases·2010
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
Prostate cancer and prostatic diseases·2010
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.
Prostate cancer and prostatic diseases·2009
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?
Journal of clinical pathology·2008
Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
Investigative urology·1981
Effects of DES on the morphology of the lobes of the baboon prostate.
Investigative urology·1981
Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
Investigative urology·1981
Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
Investigative urology·1981
Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
Investigative urology·1981
A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
Investigative urology·1981
Nanovesicle-formulated Sterculia coccinea Jack (hantap) leaf extract: Estrogen receptor-alpha molecular docking and cytotoxicity in Michigan Cancer Foundation-7 cells.
Journal of advanced pharmaceutical technology & research·2026